Literature DB >> 10782821

Amyloid myopathy masquerading as polymyositis.

L A Mandl1, R D Folkerth, M A Pick, M E Weinblatt, E M Gravallese.   

Abstract

OBJECTIVE: It is not well appreciated that the clinical presentation of amyloid myopathy can mimic that of polymyositis. By retrospective clinicopathologic analysis we determined distinctive features of amyloid myopathy that differentiate the 2 diseases.
METHODS: Two patients with clinical and histologic evidence of an inflammatory myopathy had fatal outcomes despite appropriate treatment for polymyositis. Their clinical course and original pathologic specimens were reviewed. In addition, original tissue samples were obtained and analyzed using Congo red staining and immunoperoxidase.
RESULTS: The initial diagnosis of polymyositis was supported in both cases by muscle biopsies showing inflammatory infiltrates and elevations of creatine phosphokinase and by classic electromyography. Retrospective evaluation of the initial muscle biopsies disclosed subtle but incontrovertible evidence of vascular amyloid. Further analysis of the original specimens confirmed the presence of immunoglobin light chain (AL) amyloid.
CONCLUSION: Amyloid myopathy can mimic polymyositis. Both can have similar clinical symptoms, as well as inflammatory infiltrates on muscle biopsy. Failure to recognize amyloid myopathy deprives patients of potentially life prolonging treatment. Congo red staining and immunohistochemical analysis of tissue could prevent misdiagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 10782821

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

2.  Isolated myopathy as the initial manifestation of primary systemic amyloidosis.

Authors:  D Karacostas; M Soumpourou; I Mavromatis; G Karkavelas; I Poulios; I Milonas
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

3.  Amyloid myopathy as the presenting feature of lymphoplasmacytic lymphoma.

Authors:  Zain Guduru; Abhishek Purohit; Cunfeng Pu; Sandeep Rana
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

4.  Expanding the spectrum of monoclonal light chain deposition disease in muscle.

Authors:  Lyle W Ostrow; Andrea M Corse; Brett M Morrison; Carol A Huff; John A Carrino; Ahmet Hoke; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

5.  A case of femoral compressive neuropathy in AL amyloidosis.

Authors:  Eun Ha Kang; Eun Bong Lee; Churl Hyun Im; Jin Hyun Kim; Jeong Jin Park; Jung Chan Lee; Sung Hwan Kim; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

6.  Amyloid myopathy: a diagnostic challenge.

Authors:  Heli Tuomaala; Mikko Kärppä; Hannu Tuominen; Anne M Remes
Journal:  Neurol Int       Date:  2009-11-16

7.  Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.

Authors:  Erina Ono; Akira Ishii; Yoshiaki Higashi; Natsuko Koita; Takashi Ayaki; Katsuya Tanigaki; Shunsuke Takayanagi; Naoya Kondo; Kaoru Sakai; Shuichiro Endo; Hideki Yokoi; Takeshi Matsubara; Sachiko Minamiguchi; Ichizo Nishino; Ryosuke Takahashi; Motoko Yanagita
Journal:  BMC Nephrol       Date:  2021-02-27       Impact factor: 2.388

8.  Whole Exome Sequencing Leading to the Diagnosis of Dysferlinopathy with a Novel Missense Mutation (c.959G>C).

Authors:  Abhisek Swaika; Nicole J Boczek; Neha Sood; Kimberly Guthrie; Eric W Klee; Ankit Agrawal; Elliot L Dimberg; Sikander Ailawadhi
Journal:  Case Rep Genet       Date:  2016-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.